Is it safe to use Cabergoline to restore milk? What are the precautions?

Cabergoline (Cabergoline) is a dopamine receptor agonist. It mainly inhibits the secretion of prolactin (PRL) in the anterior pituitary gland by stimulating dopamine D2 receptors in the brain, thereby achieving the effect of lactation suppression or "milk return". It is often used in postpartum situations where there is excess milk, difficulty in withdrawing milk, or medical intervention to terminate lactation. Cabergoline is well absorbed orally and has a rapid onset of action. It usually can significantly inhibit breast milk secretion within 24 to 48 hours after administration.

Clinical practice shows that cabergoline is generally safe for short-term lactation recovery. Common adverse reactions include headache, dizziness, hypotension, nausea and gastrointestinal discomfort, which are mostly mild to moderate and usually resolve spontaneously after short-term medication. Compared with traditional milk-returning drugs (such as bromocriptine or oral estrogen), cabergoline has fewer and controllable adverse reactions, so it is widely used in medical milk-returning intervention.

There are some safety precautions that you need to pay attention to when using cabergoline to restore milk. First of all, pregnant women with a history of hypertension, heart disease, arrhythmia or mental illness should use it under the guidance of a doctor to avoid hypotension or cardiovascular events. Secondly, blood pressure, heart rate, and possible symptoms such as dizziness or nausea should be monitored during the medication. If necessary, the medication can be taken in divided doses or the dose can be reduced to reduce discomfort.

In addition, cabergoline is only suitable for medically necessary short-term lactation, usually for less than a week. During use, you should avoid extending the medication time yourself or using it in combination with other dopamine agonists to prevent cumulative drug toxicity or excessive suppression of lactation function. Overall, cabergoline milk-reinstatement is safe and effective in postpartum mothers by following medical advice, paying attention to individual risk assessment, and monitoring physiological indicators.

Reference materials:https://www.drugs.com/